Sanger sequencing eventually revealed that this patient has mutations in POMT1. If flow cytometry had been used alongside immunohistochemistry, it would have immediately revealed that P13 was likely a dystroglycanopathy case. The gene discussed is POMT1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.